Santón A, Manzanal A I, Campo E, Bellas C
Department of Pathology, Ramón y Cajal Hospital, Madrid, Spain.
Clin Mol Pathol. 1995 Aug;48(4):M184-7. doi: 10.1136/mp.48.4.m184.
Aims-To analyse the latent membrane protein-1 (LMP-1) gene in a series of patients with Epstein-Barr virus (EBV) positive LMP expressing ordinary and HIV associated Hodgkin's disease to detect possible genetic alterations and particularly the existence of deletions near the 3' end of the gene.Methods-Expression of the EBV LMP-1 was assessed using immunohistochemistry in 186 cases of Hodgkin's disease and 31 cases of HIV associated Hodgkin's disease. Genomic DNA was extracted from frozen lymph node biopsy specimens from 25 cases of Hodgkin's disease and 11 of HIV associated Hodgkin's disease, all of whom expressed the LMP-1 protein within diagnostic Hodgkin and Reed-Sternberg (HRS) cells, and amplified by polymerase chain reaction (PCR) using primers specific for the different LMP-1 regions.Results-LMP-1 expression was observed in 106 of 186 Hodgkin's disease cases and in all 31 HIV associated Hodgkin's disease cases. Molecular analysis of the LMP-1 gene showed a high degree of genetic heterogeneity in the carboxy-terminal domain compared with the prototype B95-8 EBV strain, specially in the patients with HIV associated Hodgkin's disease. Variation in the size of the repeated region was found in 17 of 25 Hodgkin's disease and nine of 11 HIV associated Hodgkin's disease cases. Deletions of 30 base pairs near the 3' end of the gene were detected in all cases of HIV associated Hodgkin's disease and in six Hodgkin's disease. In one case of Hodgkin's disease a larger deletion was observed. In all patients with LMP-1 deletion mutants, 50-90% of the diagnostic HRS cells expressed the LMP-1 protein.Conclusions-The presence of the 30 base pair deletion in all cases of HIV associated Hodgkin's disease supports previous studies that reported aggressive histological and clinical behaviour in tumours harbouring this deletion. This deletion may prolong the half-life of the protein which would explain the high levels of LMP-1 expressing HRS cells in those cases carrying LMP-1 deletions. That the 30 base pair deletion was present in all of the HIV associated Hodgkin's disease specimens suggests that impairment of immune function is a stringent requirement for the expansion of malignant cells infected by EBV strains containing the deleted LMP-1 gene.
目的——分析一系列表达EB病毒(EBV)潜伏膜蛋白1(LMP-1)的普通型和HIV相关霍奇金淋巴瘤患者的LMP-1基因,以检测可能的基因改变,尤其是该基因3'端附近缺失的存在情况。方法——采用免疫组织化学方法评估186例霍奇金淋巴瘤患者和31例HIV相关霍奇金淋巴瘤患者中EBV LMP-1的表达情况。从25例霍奇金淋巴瘤患者和11例HIV相关霍奇金淋巴瘤患者的冷冻淋巴结活检标本中提取基因组DNA,所有患者在诊断性霍奇金和里德-斯腾伯格(HRS)细胞中均表达LMP-1蛋白,使用针对不同LMP-1区域的引物通过聚合酶链反应(PCR)进行扩增。结果——在186例霍奇金淋巴瘤患者中的106例以及所有31例HIV相关霍奇金淋巴瘤患者中均观察到LMP-1表达。与原型B95-8 EBV株相比,LMP-1基因的分子分析显示羧基末端结构域存在高度遗传异质性,特别是在HIV相关霍奇金淋巴瘤患者中。在25例霍奇金淋巴瘤患者中的17例以及11例HIV相关霍奇金淋巴瘤患者中的9例中发现重复区域大小存在差异。在所有HIV相关霍奇金淋巴瘤病例和6例霍奇金淋巴瘤病例中均检测到基因3'端附近30个碱基对的缺失。在1例霍奇金淋巴瘤病例中观察到更大的缺失。在所有具有LMP-1缺失突变体的患者中,50%至90%的诊断性HRS细胞表达LMP-1蛋白。结论——所有HIV相关霍奇金淋巴瘤病例中均存在30个碱基对的缺失,这支持了先前的研究,即报告了携带这种缺失的肿瘤具有侵袭性的组织学和临床行为。这种缺失可能会延长蛋白质的半衰期,这可以解释在携带LMP-1缺失的病例中LMP-1表达的HRS细胞水平较高的原因。所有HIV相关霍奇金淋巴瘤标本中均存在30个碱基对的缺失,这表明免疫功能受损是含有缺失LMP-1基因的EBV株感染的恶性细胞扩增的严格要求。